Plasmodium simiumcausing human malaria: a zoonosis with outbreak potential in the Rio de Janeiro Brazilian Atlantic forest

Abstract

SummaryBackgroundMalaria was eliminated from Southern and Southeastern Brazil over 50 years ago. However, an increasing number of autochthonous episodes attributed toPlasmodium vivaxhave been recently reported in the Atlantic forest region of Rio de Janeiro State.As P. vivax-like non-human primate malaria parasite speciesPlasmodium simiumis locally enzootic, we performed a molecular epidemiological investigation in order to determine whether zoonotic malaria transmission is occurring.MethodsBlood samples of humans presenting signs and/or symptoms suggestive of malaria as well as from local howler-monkeys were examined by microscopy and PCR. Additionally, a molecular assay based on sequencing of the parasite mitochondrial genome was developed to distinguish betweenP. vivaxandP. simium, and applied to 33 cases from outbreaks occurred in 2015 and 2016.ResultsOf 28 samples for which the assay was successfully performed, all were shown to beP. simium, indicating the zoonotic transmission of this species to humans in this region. Sequencing of the whole mitochondrial genome of three of these cases showed thatP. simiumis most closely related toP. vivaxparasites from South American.FindingsThe explored malaria outbreaks were caused byP. simium, previously considered a monkey-specific malaria parasite, related to but distinct fromP. vivax, and which has never conclusively been shown to infect humans before.InterpretationThis unequivocal demonstration of zoonotic transmission, 50 years after the only previous report ofP. simiumin man, leads to the possibility that this parasite has always infected humans in this region, but that it has been consistently misdiagnosed asP. vivaxdue to a lack of molecular typing techniques. Thorough screening of the local non-human primate and anophelines is required to evaluate the extent of this newly recognized zoonotic threat to public health and malaria eradication in Brazil.FundingFundação Carlos Chagas Filho de Amparo à Pesquisa do Estado de Rio de Janeiro (Faperj), The Brazilian National Council for Scientific and Technological Development (CNPq), JSPS Grant-in-Aid for scientific research, Secretary for Health Surveillance (SVS) of the Ministry of Health, Global Fund, and PRONEX Program of the CNPq.